Record Details

Effects of Sulforaphane and 3,3'-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells

ScholarsArchive at Oregon State University

Field Value
Title Effects of Sulforaphane and 3,3'-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells
Names Wong, Carmen P. (creator)
Hsu, Anna (creator)
Buchanan, Alex (creator)
Palomera-Sanchez, Zoraya (creator)
Beaver, Laura M. (creator)
Houseman, E. Andres (creator)
Williams, David E. (creator)
Dashwood, Roderick H. (creator)
Ho, Emily (creator)
Date Issued 2014-01-22 (iso8601)
Note This is the publisher’s final pdf. The published article is copyrighted by the author(s) and published by the Public Library of Science. The published article can be found at: http://www.plosone.org/.
Abstract Epigenetic changes, including aberrant DNA methylation, result in altered gene expression and play an important role in
carcinogenesis. Phytochemicals such as sulforaphane (SFN) and 3,3'-diindolylmethane (DIM) are promising chemopreventive
agents for the treatment of prostate cancer. Both have been shown to induce re-expression of genes, including tumor
suppressor genes silenced in cancer cells, via modulation of epigenetic marks including DNA methylation. However, it
remained unclear the effects SFN and DIM on DNA methylation at a genomic scale. The goal of this study was to determine
the genome-wide effects of SFN and DIM on promoter methylation in normal prostate epithelial cells and prostate cancer
cells. Both SFN and DIM treatment decreased DNA methyltransferase expression in normal prostate epithelial cells (PrEC),
and androgen-dependent (LnCAP) and androgen-independent (PC3) prostate cancer cells. The effects of SFN and DIM on
promoter methylation profiles in normal PrEC, LnCAP and PC3 prostate cancer cells were determined using methyl-DNA
immunoprecipitation followed by genome-wide DNA methylation array. We showed widespread changes in promoter
methylation patterns, including both increased and decreased methylation, in all three prostate cell lines in response to SFN
or DIM treatments. In particular, SFN and DIM altered promoter methylation in distinct sets of genes in PrEC, LnCAP, and
PC3 cells, but shared similar gene targets within a single cell line. We further showed that SFN and DIM reversed many of the
cancer-associated methylation alterations, including aberrantly methylated genes that are dysregulated or are highly
involved in cancer progression. Overall, our data suggested that both SFN and DIM are epigenetic modulators that have
broad and complex effects on DNA methylation profiles in both normal and cancerous prostate epithelial cells. Results from
our study may provide new insights into the epigenetic mechanisms by which SFN and DIM exert their cancer
chemopreventive effects.
Genre Article
Access Condition http://creativecommons.org/licenses/by/3.0/us/
Identifier Wong CP, Hsu A, Buchanan A, Palomera-Sanchez Z, Beaver LM, et al. (2014) Effects of Sulforaphane and 3,3'-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells. PLoS ONE 9(1): e86787. doi:10.1371/journal.pone.0086787

© Western Waters Digital Library - GWLA member projects - Designed by the J. Willard Marriott Library - Hosted by Oregon State University Libraries and Press